StockData
Attovia Therapeutics, Inc. logo

Attovia Therapeutics, Inc. (ATTO) stock

ATTONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026
$15.53+0.67 (+4.51%)

Close on Nov 18, 2026Market cap $708.96MP/E –Yield –

Attovia Therapeutics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Attovia Therapeutics's shares outstanding was 29M at Sep 30, 2026.

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 202629M–
Q2 FY2026Jun 30, 20264M–
Q3 FY2025Sep 30, 20254M–
Q2 FY2025Jun 30, 20254M–

More Attovia Therapeutics figures

See a number that looks wrong?